The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Oxalosis and Hyperoxaluria Foundation
201 East 19th Street
New York, NY 10003
The Oxalosis and Hyperoxaluria Foundation (OHF) is a national voluntary organization established to inform the public, especially affected individuals, families, physicians, and medical professionals about hyperoxaluria and related conditions such as oxalosis and calcium-oxalate kidney stones. The foundation endeavors to provide a support network to those affected by hyperoxaluria. Founded in 1989, it supports and encourages research to find a cure for hyperoxaluria. The organization publishes educational materials including a summer camp list, reprints of medical journal articles, a patient resource list, and brochures entitled "Understanding Oxalosis" and "Hyperoxaluria and Low Oxalate Diet List." The organization also supports a toll-free phone number (800) OHF-8699.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.